Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Unipharma Co., Ltd. (6621) Income Statement

Unipharma Co., Ltd. Income Statement

Last quarter (Q2 2026), Unipharma Co., Ltd.'s total revenue was NT$39.74M, a decrease of 15.41% from the same quarter last year. In Q2, Unipharma Co., Ltd.'s net income was NT$-23.36M. See Unipharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 88.44MNT$ 93.45MNT$ 103.22MNT$ 128.11MNT$ 105.39M
NT$ 41.15MNT$ 48.71MNT$ 51.02MNT$ 74.62MNT$ 59.33M
NT$ 85.27MNT$ 79.53MNT$ 78.32MNT$ 95.50MNT$ 99.55M
Depreciation and AmortizationNT$ 7.00MNT$ 7.00MNT$ 5.54MNT$ 5.53MNT$ 10.79M
NT$ -37.13MNT$ -17.71MNT$ -16.25MNT$ -1.45MNT$ -63.52M
NT$ -44.13MNT$ -30.82MNT$ -27.30MNT$ -20.88MNT$ -40.22M
NT$ 3.58MNT$ 6.00MNT$ 5.49MNT$ 13.85MNT$ -34.19M
NT$ -40.54MNT$ -24.82MNT$ -21.81MNT$ -7.03MNT$ -74.41M
NT$ -40.54MNT$ -24.82MNT$ -21.81MNT$ -6.45MNT$ -74.41M
Per Share Metrics
Basic EPSNT$ -1.14NT$ -0.70NT$ -0.61NT$ -0.18NT$ -2.11
Diluted EPSNT$ -1.14NT$ -0.70NT$ -0.61NT$ -0.18NT$ -2.11
Weighted Average Shares Outstanding35.50M35.50M35.50M35.48M35.20M
Weighted Average Shares Outstanding (Diluted)35.50M35.50M35.50M35.48M35.20M

Currency in TWD

Unipharma Co., Ltd. Earnings and Revenue History

-100M0100M200M-80 %-40 %0 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin